QuarterWatch analyzes MedWatch Reports

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant drugs are used in increasing numbers. This report also provides new evidence that drugs for erectile dysfunction and pulmonary arterial hypertension can cause deafness or sudden hearing loss.

To read this article, please click here.

Posted in

More RSI News

RSI paper on Manganese PBPK selected as a top 2017 paper

January 8, 2018
RSI logo in white

Each year the Society of Toxicology, Biological Modeling Specialty Section (BMSS) does a literature search to identify outstanding modeling papers in the field of toxicology.…

Read News Item

RSI and Engineers Canada develop on-line training courses

October 26, 2017
RSI logo in white

Engineers Canada has retained Risk Sciences International’s (RSI) Climate Group to develop training course modules and to deliver on-line training to Professional Engineers seeking to…

Read News Item

Roger Rempel joins RSI as Director of Climate Group

February 28, 2017
RSI logo in white

RSI is pleased to announce that Roger Rempel has joined us as the Director of the RSI Climate Group. Roger is a senior environmental engineer…

Read News Item

Norman Shippee joins RSI

February 28, 2017
RSI logo in white

RSI is pleased to announce that Norman Shippee recently joined the team as a Climate and Applications Specialist. Dr. Shippee earned his PhD at the…

Read News Item